Gender-Affirming Hormone Therapy and Its Impact on Myocardial Mass and Cardiac Function, Heart, Liver and Pancreatic Fat Content
Conditions: Gender Dysphoria; Hormone Therapy Induced Morphologic Change Interventions: Drug: gender-affirming hormone therapy Sponsors: Medical University of Vienna Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 4, 2024 Category: Research Source Type: clinical trials
Assessment of Microorganisms and Host Response In Liver Diseases
Conditions: Gut Microbiome; Liver Diseases Sponsors: University of Aberdeen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 4, 2024 Category: Research Source Type: clinical trials
Factors Associated With Posttransplant Cardiac Outcomes
Conditions: Cardiovascular Diseases; Liver Transplantation Sponsors: Sun Yat-sen University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 4, 2024 Category: Research Source Type: clinical trials
Evaluation of the Ablation of Hepatic Lesions by Electroporation
Conditions: Liver Cancer Sponsors: Assistance Publique - H ôpitaux de Paris; Inria Team MONC Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 4, 2024 Category: Research Source Type: clinical trials
Long-term Outcomes of Living Donor Liver Transplantations With Anti-HBc (+) Grafts in Pediatric Patients
Conditions: Living Donor Liver Transplantations With Anti-HBc (+) Grafts Sponsors: Chang Gung Memorial Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 4, 2024 Category: Research Source Type: clinical trials
Combining Gene Variants to Improve Risk Prediction for Metabolic (Dysfunction)- Associated Fatty Liver Disease and Its Progression to Cirrhosis in Indian Individuals With Type 2 Diabetes
Conditions: Type2diabetes Sponsors: Medanta, The Medicity, India Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 1, 2024 Category: Research Source Type: clinical trials
French Assessment of MRD by Liquid Biopsies in Colorectal With Liver Metastasis Patients (FRENCH.MRD.CRLM)
Conditions: Colorectal Cancer; Liver Metastases; Stage IV Colorectal Cancer; Minimal Residual Disease; Liquid Biopsy; ctDNA Interventions: Biological: Blood sample/Liquid biopsy Sponsors: University Hospital, Montpellier Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 1, 2024 Category: Research Source Type: clinical trials
miroliverELAP ® for the Treatment of Acute Liver Failure: A Phase 1 Trial
Conditions: Acute Liver Failure; Acute Liver Injury, Drug Induced Interventions: Combination Product: miroliverELAP treatment Sponsors: Miromatrix Medical Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 29, 2024 Category: Research Source Type: clinical trials
Study on Roujin Formula in the Treatment of Fibromyalgia Syndrome With Blood Deficiency and Liver Depression
Conditions: Fibromyalgia Syndrome Interventions: Drug: Roujin Formula Sponsors: Guang ' anmen Hospital of China Academy of Chinese Medical Sciences Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 29, 2024 Category: Research Source Type: clinical trials
A Clinical Cohort Study on the Pathogen Spectrum of Hepatic Virus-caused Cirrhosis Complicated With Infection
Conditions: Liver Cirrhosis Sponsors: Zhejiang University; Beijing Ditan Hospital; Beijing YouAn Hospital; Huashan Hospital; Qilu Hospital of Shandong University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials
A Clinical Study of BioTTT001 in Combination With Toripalimab and Regorafenib in Patients With Liver Metastases From Colorectal Cancer
Conditions: Colorectal Cancer Metastatic Interventions: Biological: BioTTT001 hepatic artery infusion; Drug: toripalimab; Drug: regorafenib Sponsors: China Medical University, China; Beijing Bio-Targeting Therapeutics Technology Co., Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials
Neoadjuvant Serplulimab & Bevacizumab With FOLFOX vs. FOLFOX Alone in RAS/BRAF WT, pMMR/MSS CRC Patients
Conditions: Colorectal Cancer; Liver Metastases Interventions: Drug: Oxaliplatin; Drug: Fluorouracil; Drug: Serplulimab; Drug: Bevacizumab Sponsors: Sun Yat-sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials
Expanding Liver Transplant Immunosuppression Minimization Via Everolimus
Conditions: Liver Transplant Interventions: Drug: Everolimus; Drug: Tacrolimus (continued reduction); Drug: Tacrolimus (maintain 50% reduction); Drug: Everolimus Sponsors: National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials
A Cohort Study on the Pathogen Spectrum of Liver Transplant Recipients Complicated With Infection
Conditions: Liver Transplantation; Transplant Recipients Sponsors: Zhejiang University; Beijing Ditan Hospital; Beijing YouAn Hospital; Huashan Hospital; Qilu Hospital of Shandong University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials
A Clinical Study of T3011 in Combination With Toripalimab and Regorafenib in Patients With Liver Metastases From Colorectal Cancer
Conditions: Colorectal Cancer Metastatic Interventions: Biological: T3011 hepatic artery infusion; Drug: toripalimab; Drug: regorafenib Sponsors: China Medical University, China; Immvira Co., Limited Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials
